Genetic dissection of pigment dispersing iris disease
Genetic dissection of pigment dispersing iris disease
批准号:
7928399
负责人:
Michael G Anderson
金额:
$12.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2010-09-29
关键词:
AllelesAnimal ModelAntioxidantsBindingBlindnessCHS1 geneCellular MorphologyColorDataDevelopmentDiseaseDissectionEarly treatmentEmployee StrikesEventExfoliation SyndromeExhibitsEyeEye diseasesFutureGenesGeneticGenetic ScreeningGenetic screening methodGlaucomaGoalsHumanHuman GeneticsIn VitroInterventionIris DiseasesIsoleucineKnowledgeMediatingMedicalMelanogenesisModelingMouse StrainsMusMutant Strains MiceMutationOpen-Angle GlaucomaOutcomeOxidative StressPathway interactionsPatientsPhenotypePhysiologyPigmentsPredispositionProteinsResourcesRiskRoleScreening procedureTechniquesTestingTherapeuticTwo-Hybrid System TechniquesVariantWD RepeatWorkYeastsage relatedanterior chamberbasecasein kinase IIdisease phenotypeexpectationgenetic analysisgenetic associationhuman diseaseimprovedinnovationmouse modelmutantoxidative damageprotein protein interactionresearch studytrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pseudoexfoliation syndrome is a common age-related disease of worldwide significance and is the most commonly identified specific cause of open-angle glaucoma. The disease initiating mechanisms of pseudoexfoliation syndrome are almost completely unknown. Currently, all therapeutic strategies for pseudoexfoliative glaucoma aim to lower IOP and there are no specific therapies aimed at treating pseudoexfoliation syndrome itself. With increased knowledge of the initiating mechanisms, it should be possible to devise improved therapeutic strategies that specifically target pseudoexfoliation syndrome itself, promoting earlier interventions and improved medical outcomes. Our long-term goal is to contribute to the development of improved human glaucoma therapies by utilizing synergistic genetic approaches with mice and humans. Here, we take advantage of a phenotype-driven screening approach among mouse coat color variants that has identified a new mouse model of eye disease that strongly resembles aspects of pseudoexfoliation syndrome. Our objective in this proposal is to capitalize on this resource by initiating mechanistic studies and completing a phenotypic characterization of the strain. Using genetic approaches in mice, we are testing the hypothesis that susceptibility of the eye toward PEX syndrome is mediated via a mechanism influencing cellular morphology and oxidative stress associated with melanogenesis. Suspecting that the same mechanism likely underlies human PEX syndrome, we are simultaneously conducting human genetic association studies. Completion of these studies will not only identify PEX syndrome-related genetic pathways, but will also develop an animal model needed for development and testing of future therapeutic strategies. In the long-term, these experiments will contribute to a better understanding of glaucoma, and ultimately, to improved human therapies. Pseudoexfoliation syndrome is a common age-related disease of worldwide significance and is the most commonly identified specific cause of open-angle glaucoma. Here, we take advantage of a newly identified mouse model that strongly resembles aspects of pseudoexfoliation syndrome. Our objective in this proposal is to test the genetic pathways contributing to phenotypes of this mouse strain and test the significance of these genes among human pseudoexfoliation patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of APBB2 contributions to glaucoma
-
批准号:10248474
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2020
-
负责人:Michael G Anderson
-
依托单位:
Genetic modifiers of Cep290-mediated retinal degeneration
-
批准号:9759929
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2018
-
负责人:Michael G Anderson
-
依托单位:
Rodent Phenotyping Core
-
批准号:10663391
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2016
-
负责人:Michael G Anderson
-
依托单位:
Rodent Phenotyping Core
-
批准号:10488232
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2016
-
负责人:Michael G Anderson
-
依托单位:
Rodent Phenotyping Core
-
批准号:10271731
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2016
-
负责人:Michael G Anderson
-
依托单位:
Therapy of Nocturnal Intraocular Pressure Elevation Causing Glaucoma Progression
-
批准号:8986673
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Michael G Anderson
-
依托单位:
Therapy of Nocturnal Intraocular Pressure Elevation Causing Glaucoma Progression
-
批准号:9182823
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigment dispersing iris disease
-
批准号:8035326
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigment dispersing iris disease
-
批准号:7370078
-
项目类别:
-
资助金额:$33.46万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigment dispersing iris disease
-
批准号:8230755
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigment dispersing iris disease
-
批准号:8012905
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigmentary glaucoma
-
批准号:9000701
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Pigmentation-dependent melanosomal disease
-
批准号:7362513
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigment dispersing iris disease
-
批准号:7587920
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigment dispersing iris disease
-
批准号:7777285
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigmentary glaucoma
-
批准号:8798658
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Pigmentation-dependent melanosomal disease
-
批准号:7582344
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Pigmentation-dependent melanosomal disease
-
批准号:7769509
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
Genetic dissection of pigmentary glaucoma
-
批准号:8630603
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2008
-
负责人:Michael G Anderson
-
依托单位:
海外基金